MIKART
Mikart is a contract development and manufacturing organization (CDMO) delivering an integrated suite of services spanning the entire drug development and commercialization lifecycle. From early concept through launch and market expansion, Mikart serves as a trusted industry partner, drawing on more than 50 years of experience delivering high-quality products that consistently exceed the most rigorous client and regulatory standards.
Our commitment to long-term partnerships, combined with a collaborative and agile approach, enables us to design flexible solutions tailored to your unique needs. Transparency, reliability, and responsiveness define the Mikart experience and underpin the expert, adaptable strategies we use to advance your product at every stage.
Rely on our proven expertise in oral solid and non-sterile oral liquid dosage forms—including specialized capabilities in pediatric and geriatric formulations, as well as controlled substances—from formulation development through full-scale commercialization.
INDUSTRY INSIGHTS
-
Accelerate the development of complex liquid suspensions and bring patient-centric formulations from concept to commercialization by leveraging specialized expertise, advanced technologies, and dedicated facilities.
-
Discover how early developability assessments and a quality-by-design approach can streamline formulation, reduce risk, and accelerate your path to successful, cost-effective drug development.
-
Leverage the expertise of experienced project managers to select the right CDMO partner, mitigate risk, and drive your pharmaceutical program toward faster, more successful outcomes.
-
Liquid suspension formulations are rapidly growing in pharma, driven by patient needs, formulation advances, and CDMO innovation.
-
Cannabinoid and psilocybin therapies are advancing rapidly, and Mikart supports innovators with DEA-licensed facilities, formulation expertise, regulatory guidance, and manufacturing capabilities from clinical development to commercialization.
-
Choosing the right CDMO is essential for biotech commercialization. Key factors include regulatory expertise, integrated services, scalability, communication, flexibility, and strong technical and packaging capabilities
-
Leverage minitablet technology to create flexible, easy-to-swallow, and palatable pediatric formulations that improve adherence and meet evolving regulatory requirements.
-
Improve medication adherence and health outcomes by developing patient-friendly dosage forms that enhance swallowability and palatability for pediatric, geriatric, and dysphagic populations.
CONTACT INFORMATION
Mikart
1750 Chattahoochee Ave.
Atlanta, GA 30318
UNITED STATES
Phone: 888-464-5278
Contact: Louis Weber, VP Business Development Email: Lweber@mikart.com Phone: 570-262-8469
NEWS
- Mikart Celebrates 50 Years Of Excellence In Pharmaceutical Manufacturing
- Mikart Signs Lease For New Headquarters At Cumberland Center II In Northwest Atlanta
SOLUTIONS
-
The FlexPack NF-150 Horizontal Pouch-Packaging Machine is a high-performance packaging machine due to its versatility, productivity, and easy changeover.
-
Mikart offers a wide range of bottle filling options personalized to your needs.
-
Unit dose cups are a convenient and cost-efficient method to distribute your non-sterile oral liquid dose product — an ideal liquid-dosage delivery method.
-
As part of Mikart’s essential clinical trial supply services, we offer customized cartons and trays.
-
As practical as they are cost-effective, pouches and foil strip packs are versatile solutions for pediatrics, geriatrics, and controlled substances, while laminated foil pouches provide convenient physician sampling and unit dose packaging.
-
Mikart manufactures a range of blister pack solutions — including blister pack tablets, 2-piece hard- and softgel capsules, and more — as part of our commercial pharmaceutical packaging and clinical trial packaging services.